ITGB4 and cancer: To determine whether MBZ treatment reduced the ITGβ4-positive TNBC population in MDA-MB-231 and SUM159 cells and reduced the population of cells expressing the conventional cancer stem cell markers (CSC) (CD44hiCD24low), we analyzed the percent of CD44hiCD24low cells within the ITGβ4-positive population.